DK1200561T3 - Rekombinant stabil celleklon, dens fremstilling og anvendelse - Google Patents

Rekombinant stabil celleklon, dens fremstilling og anvendelse

Info

Publication number
DK1200561T3
DK1200561T3 DK99939251T DK99939251T DK1200561T3 DK 1200561 T3 DK1200561 T3 DK 1200561T3 DK 99939251 T DK99939251 T DK 99939251T DK 99939251 T DK99939251 T DK 99939251T DK 1200561 T3 DK1200561 T3 DK 1200561T3
Authority
DK
Denmark
Prior art keywords
cell clone
stabile
proteins
recombinant
preparation
Prior art date
Application number
DK99939251T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Mundt
Friedrich Dorner
Manfred Reiter
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3683861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1200561(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK1200561T3 publication Critical patent/DK1200561T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK99939251T 1999-08-05 1999-08-05 Rekombinant stabil celleklon, dens fremstilling og anvendelse DK1200561T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AT1999/000197 WO2001011021A1 (de) 1999-08-05 1999-08-05 Rekombinanter stabiler zellklon, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
DK1200561T3 true DK1200561T3 (da) 2006-10-16

Family

ID=3683861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99939251T DK1200561T3 (da) 1999-08-05 1999-08-05 Rekombinant stabil celleklon, dens fremstilling og anvendelse

Country Status (11)

Country Link
EP (1) EP1200561B1 (ja)
JP (1) JP2003506077A (ja)
AT (1) ATE330003T1 (ja)
AU (1) AU780810B2 (ja)
CA (1) CA2381173A1 (ja)
CY (1) CY1106111T1 (ja)
DE (1) DE59913565D1 (ja)
DK (1) DK1200561T3 (ja)
ES (1) ES2267280T3 (ja)
PT (1) PT1200561E (ja)
WO (1) WO2001011021A1 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP4477299B2 (ja) * 2000-10-02 2010-06-09 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 因子ｖｉｉグリコ型
ES2291534T3 (es) 2001-10-02 2008-03-01 Novo Nordisk Health Care Ag Metodo para la produccion de proteinas recombinantes en celulas eucariotas.
WO2003045995A2 (en) * 2001-11-28 2003-06-05 Sandoz Gmbh Cell culture process
AU2002354363A1 (en) * 2001-12-04 2003-06-17 Mitsubishi Pharma Corporation Method of activating protein
CN101058800B (zh) 2002-07-09 2013-03-13 巴克斯特国际有限公司 用于细胞培养的无动物蛋白质培养基
DE10338531A1 (de) * 2003-08-19 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Reklonierung von Produktionszellen
US8669109B2 (en) 2003-08-19 2014-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of producing proteins in Chinese hamster ovary (CHO) cells
RU2370276C2 (ru) * 2003-12-31 2009-10-20 Мерк Патент Гмбх Fc-ЭРИТРОПОЭТИН СЛИТЫЙ БЕЛОК С УЛУЧШЕННОЙ ФАРМАКОКИНЕТИКОЙ
AU2011221414B2 (en) * 2004-10-29 2012-09-20 Takeda Pharmaceutical Company Limited Animal Protein-Free Media for Cultivation of Cells
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1851305B1 (en) 2005-02-11 2012-01-18 Novo Nordisk Health Care AG Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
DK2522717T3 (da) 2006-01-04 2014-04-22 Baxter Int Oligopeptid-frie cellekulturmedier
EP2977461A1 (en) 2008-11-12 2016-01-27 Baxalta Incorporated Method of producing serum-free insulin-free factor vii
WO2024024671A1 (ja) * 2022-07-27 2024-02-01 不二製油グループ本社株式会社 動物細胞増殖促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
DE4313620A1 (de) * 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
EP0666312A1 (en) * 1994-02-08 1995-08-09 Wolfgang A. Renner Process for the improvement of mammalian cell growth
ATE429246T1 (de) * 1994-11-10 2009-05-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freiem kultur
EP0799310A1 (en) * 1994-12-16 1997-10-08 Novartis AG Production of recombinant secretory component
AUPN442295A0 (en) * 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein

Also Published As

Publication number Publication date
ATE330003T1 (de) 2006-07-15
AU5363699A (en) 2001-03-05
EP1200561A1 (de) 2002-05-02
EP1200561B1 (de) 2006-06-14
PT1200561E (pt) 2006-09-29
CY1106111T1 (el) 2011-06-08
AU780810B2 (en) 2005-04-21
JP2003506077A (ja) 2003-02-18
WO2001011021A1 (de) 2001-02-15
CA2381173A1 (en) 2001-02-15
ES2267280T3 (es) 2007-03-01
DE59913565D1 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DK15182A (da) Fremgangsmaade til fremstilling af recombinant-dna
HUP0101136A2 (hu) Fehérjeexpresszió baculovírus-vektort alkalmazó expressziós rendszerben
BR0107474A (pt) Preparação de proteìnas e permuteìnas desalergenizadas
DE69332981D1 (de) Methoden zur herstellung löslicher, oligomerer proteine
CA2095852A1 (en) Proteins with changed epitopes and methods for the production thereof
DK0690127T3 (da) Sammensætninger og fremgangsmåder til stimulering af megakaryocytvækst og -differentiering
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
HUP0303843A2 (hu) CLyA-hemolizin alkalmazása proteinek exkretáltatására
DE69636899D1 (de) Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
ES2059367T3 (es) Produccion de proteinas mediante cultivo de celulas.
KR890005272A (ko) 흉선 간질-유래 t세포 성장인자 및 그의 제조방법
DE69425809T2 (de) Methoden zur Herstellung von Protein C
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
TW200700553A (en) Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
ATE168117T1 (de) Proteine mit onkostatin-m-aktivität und verfahren zu ihrer herstellung
LT2005053A (en) Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
DE69923595D1 (de) Herstellung von proteinen
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DE60033562D1 (de) Künstliche promotoren zür protein expression in pflanzen
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
NO933268L (no) Fremgangsmaate for fremstilling av protein fra udoedelige celler dyrket in vivo
JPS57202287A (en) Cultivation and preparation of urokinase by it